Explanipedia

Immune responses after two inactivated COVID-19 vaccine doses, a heterologous third dose and subsequent boosting with bivalent mRNA in adults Open

Sant Muangnoicharoen, Saranath Lawpoolsri, Viravarn Luvira, Anan Jongkaewwattana, Sira Nanthapisal , et al. · 2025

To evaluate immune response and safety of a bivalent mRNA booster (ancestral/BA.4/5) vaccine in individuals who had received inactivated COVID-19 vaccine with different heterologous boost regimens. A prospective open-label study of bivalen…

Prevalence and associated factors of intestinal parasitic infections among schoolchildren in Jalalabad, Afghanistan Open

Ahadollah Azami, Noppadon Tangpukdee, Sant Muangnoicharoen, Polrat Wilairatana · 2025

Immune Responses of Adults Previously Received Two Doses of Inactivated Covid-19 Vaccines, and Third Dose of Any Covid-19 Vaccine Boosted with Bivalent Mrna Ancestral/Omicron Ba.4/5 Vaccine Open

Sant Muangnoicharoen, Saranath Lawpoolsri Niyom, Juthaporn Cowan, Viravarn Luvira, Anan Jongkaewwattana , et al. · 2025

Immune Responses to a Heterologous Booster with Mrna Based Covid-19 Vaccine after Priming with an Inactivated Newcastle Disease Virus Recombinant Vaccine Expressing the Sars-Cov-2 Spike Protein (Ndv-Hxp-S) Open

Viravarn Luvira, Saranath Lawpoolsri Niyom, Weerapong Phumratanaprapin, Anan Jongkaewwattana, Sira Nanthapisal , et al. · 2025

Heterologous Ad26.COV2.S booster after primary BBIBP-CorV vaccination against SARS-CoV-2 infection: 1-year follow-up of a phase 1/2 open-label trial Open

Sant Muangnoicharoen, Rakpong Wiangcharoen, Saranath Lawpoolsri, Sira Nanthapisal, Anan Jongkaewwattana , et al. · 2024

NCT05109559.

Heterologous Ad26.Cov2.S Booster after Primary Bbibp-Corv Vaccination Against Sars-Cov-2 Infection: 1-Year Follow-Up of a Phase 1/2 Open-Label Trialheterologous Ad26.Cov2.S Booster after Primary Bbibp-Corv Vaccination Against Sars-Cov-2 Infection: 1-Year Follow-Up of a Phase 1/2 Open-Label Trial Open

Sant Muangnoicharoen, Rakpong Wiangcharoen, Saranath Lawpoolsri, Sira Nanthapisal, Anan Jongkaewwattana , et al. · 2024

Single Ad26.COV2.S booster dose following two doses of BBIBP-CorV vaccine against SARS-CoV-2 infection in adults: Day 28 results of a phase 1/2 open-label trial Open

Sant Muangnoicharoen, Rakpong Wiangcharoen, Sira Nanthapisal, Supitcha Kamolratakul, Saranath Lawpoolsri , et al. · 2023

NCT05109559.

An inactivated NDV-HXP-S COVID-19 vaccine elicits a higher proportion of neutralizing antibodies in humans than mRNA vaccination Open

Juan Manuel Carreño, Ariel Raskin, Gagandeep Singh, Johnstone Tcheou, Hisaaki Kawabata , et al. · 2023

NDV-HXP-S is a recombinant Newcastle disease virus–based vaccine against SARS-CoV-2, which expresses an optimized (HexaPro) spike protein on its surface. The vaccine can be produced in embryonated chicken eggs using the same process as tha…

Single Ad26.COV2.S Booster Dose Following Two Doses of BBIBP-CorV Vaccine Against SARS-CoV-2 Infection in Adults: Day 28 Results of a Phase 1/2 Open-Label Trial Open

Sant Muangnoicharoen, Rakpong Wiangcharoen, Sira Nanthapisal, Supitcha Kamolratakul, Saranath Lawpoolsri Niyom , et al. · 2023

False Positivity of Anti-SARS-CoV-2 Antibodies in Patients with Acute Tropical Diseases in Thailand Open

Viravarn Luvira, Pornsawan Leaungwutiwong, Narin Thippornchai, Charin Thawornkuno, Supawat Chatchen , et al. · 2022

Serology remains a useful indirect method of diagnosing tropical diseases, especially in dengue infection. However, the current literature regarding cross-reactivity between SARS-CoV-2 and dengue serology is limited and revealed conflictin…

Mortality in Thai Nursing Homes Based on Antimicrobial-Resistant Enterobacterales Carriage and COVID-19 Lockdown Timing: A Prospective Cohort Study Open

Thundon Ngamprasertchai, Muthita Vanaporn, Sant Muangnoicharoen, Wirichada Pan–ngum, Narisa Ruenroengbun , et al. · 2022

Antimicrobial-resistant Enterobacterales carriage and the coronavirus disease 2019 (COVID-19) lockdown measures may impact the incidence all-cause mortality rate among nursing home residents. To determine the all-cause mortality rate in th…

Determination of ceftriaxone in human plasma using liquid chromatography–tandem mass spectrometry Open

Thamrong Wongchang, Markus Winterberg, Joel Tärning, Natthida Sriboonvorakul, Sant Muangnoicharoen , et al. · 2022

Ceftriaxone is a cephalosporin antibiotic drug used as first-line treatment for a number of bacterial diseases. Ceftriaxone belongs to the third generation of cephalosporin and is available as an intramuscular or intravenous injection. Pre…

Protein and antigen profiles of third-stage larvae of Gnathostoma spinigerum assessed with next-generation sequencing transcriptomic information Open

Kathyleen Nogrado, Tipparat Thiangtrongjit, Poom Adisakwattana, Paron Dekumyoy, Sant Muangnoicharoen , et al. · 2022

Safety and immunogenicity of an inactivated recombinant Newcastle disease virus vaccine expressing SARS-CoV-2 spike: Interim results of a randomised, placebo-controlled, phase 1 trial Open

Punnee Pitisuttithum, Viravarn Luvira, Saranath Lawpoolsri, Sant Muangnoicharoen, Supitcha Kamolratanakul , et al. · 2022

The inactivated NDV-HXP-S COVID-19 vaccine induces a significantly higher ratio of neutralizing to non-neutralizing antibodies in humans as compared to mRNA vaccines Open

Juan Manuel Carreño, Ariel Raskin, Gagandeep Singh, Johnstone Tcheou, Hisaaki Kawabata , et al. · 2022

NDV-HXP-S is a recombinant Newcastle disease virus based-vaccine against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), which expresses an optimized (HexaPro) spike protein on its surface. The vaccine can be produced in embr…

Low Branched Chain Amino Acids and Tyrosine in Thai Patients with Type 2 Diabetes Mellitus Treated with Metformin and Metformin-Sulfonylurea Combination Therapies Open

Natthida Sriboonvorakul, Wirichada Pan–ngum, Kittiyod Poovorawan, Sant Muangnoicharoen, Lauren M. Quinn , et al. · 2021

Type 2 diabetes mellitus (T2DM) is a growing public health challenge for Thailand (current prevalence ~10.0%). Amino acids offer novel biomarkers to predict risk of T2DM and indicate sub-optimal disease management, which could facilitate e…

Knowledge, attitude, and practices toward COVID-19 among the international travelers in Thailand Open

Suttiporn Prapaso, Viravarn Luvira, Saranath Lawpoolsri, Archin Songthap, Watcharapong Piyaphanee , et al. · 2021

Safety and Immunogenicity of an Inactivated Recombinant Newcastle Disease Virus Vaccine Expressing SARS-CoV-2 Spike: Interim Results of a Randomised, Placebo-Controlled, Phase 1/2 Trial Open

Punnee Pitisuttithum, Viravarn Luvira, Saranath Lawpoolsri, Sant Muangnoicharoen, Supitcha Kamolratanakul , et al. · 2021

Summary Background Production of affordable coronavirus disease 2019 (COVID-19) vaccines in low- and middle-income countries is needed. NDV-HXP-S is an inactivated egg-based Newcastle disease virus vaccine expressing the spike protein of s…

Cardiac evaluation in adults with dengue virus infection by serial echocardiography Open

Chayasin Mansanguan, Borimas Hanboonkunupakarn, Sant Muangnoicharoen, Arun Huntrup, Akkapon Poolcharoen , et al. · 2021

Determination of ceftriaxone in human plasma using liquid chromatography–tandem mass spectrometry Open

Thamrong Wongchang, Markus Winterberg, Joel Tärning, Natthida Sriboonvorakul, Sant Muangnoicharoen , et al. · 2021

Ceftriaxone is a cephalosporin antibiotic drug used as first-line treatment for a number of bacterial diseases. Ceftriaxone belongs to the third generation of antibiotics and is available as an intramuscular or intravenous injection. Previ…

Risk Factors for HIV sero-conversion in a high incidence cohort of men who have sex with men and transgender women in Bangkok, Thailand Open

Tanyaporn Wansom, Sant Muangnoicharoen, Sorachai Nitayaphan, Suchai Kitsiripornchai, Trevor A. Crowell , et al. · 2021

Risk Factors for HIV Seroconversion in a High Incidence Cohort of Men Who Have Sex with Men and Transgender Women in Bangkok, Thailand Open

Tanyaporn Wansom, Sant Muangnoicharoen, Sorachai Nitayaphan, Suchai Kitsiripornchai, Trevor A. Crowell , et al. · 2021

Assessment of the amino acid profile in Thai patients with type 2 diabetes mellitus using liquid chromatography-mass spectrometry Open

Natthida Sriboonvorakul, Wirichada Pan–ngum, Kittiyod Poovorawan, Markus Winterberg, Joel Tärning , et al. · 2020

Background Type 2 diabetes mellitus (T2DM) is a global health problem. Early identification of those at risk is necessary to prevent its onset through lifestyle and pharmacologic interventions. T2DM is characterized by metabolic abnormalit…

Temporal Change of SARS-CoV-2 in Clinical Specimens of COVID-19 Pneumonia Patients Open

Viravarn Luvira, Akanitt Jittmittraphap, Sant Muangnoicharoen, Nantarat Chantawat, Weena Janwitthayanan , et al. · 2020

The quality and type of specimen collection affect the sensitivity of real-time reverse transcriptase-PCR (rRT-PCR) for the diagnosis of SARS-CoV-2. In this report, the course over time of rRT-PCR for SARS-CoV-2 in 26 clinical specimens co…

Cardiac evaluation in adults with dengue virus infection by serial echocardiography Open

Chayasin Mansanguan, Borimas Hanboonkunupakarn, Sant Muangnoicharoen, Arun Huntrap, Akkapon Poolcharoen , et al. · 2020

Background Dengue virus infection (DVI) is a major health problem in many parts of the world. Its manifestations range from asymptomatic infections to severe disease. Although cardiac involvement has been reported in DVI, its incidence has…

Case Report: COVID-19 Presenting as Acute Undifferentiated Febrile Illness—A Tropical World Threat Open

Surat Nunthavichitra, Suttiporn Prapaso, Viravarn Luvira, Sant Muangnoicharoen, Pornsawan Leaungwutiwong , et al. · 2020

We report a young Thai man from the Thai-Myanmar border suffering from 2 days of fever and myalgia without respiratory tract signs or symptoms. He reported no history of travel through an area with confirmed COVID-19 cases or contact with …

Diabetes mellitus as a prognostic factor for dengue severity: Retrospective study from Hospital for Tropical Diseases, Bangkok Open

Khaing Zaw Latt, Kittiyod Poovorawan, Natthida Sriboonvorakul, Wirichada Pan‐ngum, Natavudh Townamchai , et al. · 2020

Objective: The study was conducted to determine whether or not diabetes mellitus is a prognostic factor for dengue severity among patients infected with dengue-virus infection and admitted to the Hospital for Tropical Diseases, Bangkok, be…

Case Report: Walking Pneumonia in Novel Coronavirus Disease (COVID-19): Mild Symptoms with Marked Abnormalities on Chest Imaging Open

Chaisith Sivakorn, Viravarn Luvira, Sant Muangnoicharoen, Pittaya Piroonamornpun, Tharawit Ouppapong , et al. · 2020

This case report underlines the appearance of a “walking pneumonia” in a novel coronavirus disease (COVID-19) patient, with evidence of progressive lung involvement on chest imaging studies. The patient traveled from Wuhan, Hubei, China, t…

Cytokine Expression in Dengue Fever and Dengue Hemorrhagic Fever Patients with Bleeding and Severe Hepatitis Open

Hisham Ahmed Imad, Weerapong Phumratanaprapin, Benjaluck Phonrat, Kesinee Chotivanich, Prakaykaew Charunwatthana , et al. · 2020

Dengue is the most common mosquito-borne flaviviral infection in the world today. Several factors contribute and act synergistically to cause severe infection. One of these is dysregulated host immunological mediators that cause transient …

Determination of ceftriaxone in human plasma using liquid chromatography–tandem mass spectrometry Open

Thamrong Wongchang, Markus Winterberg, Joel Tärning, Natthida Sriboonvorakul, Sant Muangnoicharoen , et al. · 2019

Ceftriaxone is a cephalosporin antibiotic drug used as first-line treatment for several bacterial diseases. Ceftriaxone belongs to the third generation of antibiotics and is available as an intramuscular or intravenous injection. Previousl…

Sant Muangnoicharoen YOU? Author Swipe